Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

Market Cap	7.01B -10.4%
Revenue (ttm)	7.13B -5.0%
Net Income	250.38M -35.6%
EPS	0.17 -36.3%
Shares Out	1.43B
PE Ratio	28.08
Forward PE	n/a
Dividend	0.06 (1.14%)
Ex-Dividend Date	Jun 23, 2025

Volume	4,728,281
Average Volume	14,140,987
Open	4.870
Previous Close	4.910
Day's Range	4.810 - 4.910
52-Week Range	4.650 - 6.680
Beta	0.09
RSI	42.09
Earnings Date	Aug 27, 2026

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals manufacturing, pharmaceutical distribution, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti- infective products, such as fosfomycin series, azithromycin series, amantadine series, polyalkali hydrochloride, chloramphenicol, and other products; and reproductive system and hormone products comprising carboprost suppositories, carboprost tromet...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 5,727
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000597

Financial Performance

In 2025, SHE:000597's revenue was 7.07 billion, a decrease of -5.70% compared to the previous year's 7.50 billion. Earnings were 260.07 million, a decrease of -36.54%.